Compassion Training May Up Resilience to Others' Suffering

Share this content:
Compassion Training May Up Resilience to Others' Suffering
Compassion Training May Up Resilience to Others' Suffering

MONDAY, July 16, 2018 (HealthDay News) -- Compassion meditation can increase the visual preference for suffering while attenuating neural responses in regions of the brain associated with valence and empathic distress, according to a study published recently in Frontiers in Psychology.

Helen Y. Weng, Ph.D., from the University of California in San Francisco, and colleagues randomized healthy adults to two weeks of compassion or reappraisal training. Blood-oxygen-level-dependent functional magnetic resonance imaging responses were measured before and after training while participants viewed images depicting human suffering or non-suffering.

The researchers observed a correlation for increases in visual preference for suffering due to compassion training with decreases in the amygdala, which is involved in negative valence, arousal, and physiological responses typical of fear and anxiety states. The pattern was seen in the compassion group but not the reappraisal group. There was also a correlation for compassion training-related increases in visual preference for suffering with decreases in regions sensitive to valence and empathic distress, spanning the anterior insula and orbitofrontal cortex; the opposite effect was seen in the reappraisal group. Compared with engaging in reappraisal, engaging in compassion in general resulted in visual attention preference for suffering on examining visual attention alone.

"Compassion meditation may shift habits of becoming overly distressed when we encounter another's pain," Weng said in a statement. "People can learn a calmer and more balanced response when they see someone suffering, even when they are attending more to suffering."

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »